Reviva Pharmaceuticals Holdings, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$39.36 thousand for the 3-month period ending 2019-05-31, per its 10-Q filed 2019-07-03.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-07-03
- Reviva Pharmaceuticals Holdings, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-05-31 was -$39.36K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 2 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 5 month | Cash and Cash Equivalents, Period Increase (Decrease) 8 month | Cash and Cash Equivalents, Period Increase (Decrease) 11 month |
|---|---|---|---|---|---|
| 2019-05-31 | -$39.36K 10-Q · filed 2019-07-03 | ||||
| 2019-02-28 | $313.05K 10-K · filed 2019-05-22 | ||||
| 2018-11-30 | $400.96K 10-Q · filed 2019-01-09 | ||||
| 2018-08-31 | $441.57K 10-Q · filed 2018-10-11 | ||||
| 2018-05-31 | $30.00K 10-Q · filed 2019-07-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |